RXRX - RECURSION PHARMACEUTICALS, INC.

3.64
0.100   2.747%

Share volume: 16,101,964
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.44%

PREVIOUS CLOSE
CHG
CHG%
$3.54
0.10
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025
Report Date 05-09-2024 08-08-2024 11-06-2024 02-28-2025 05-05-2025 11-05-2025 02-25-2026
Total revenue 13.794 M 14.417 M 26.082 M 4.546 M 14.745 M 5.175 M 35.538 M
Cost of revenue 11.166 M 9.199 M 12.079 M 12.794 M 21.829 M 14.687 M 14.276 M
Gross profit 2.628 M 5.218 M 14.003 M -8.248 M -7.084 M -9.512 M 21.262 M
    98.55% 168.36% -158.90% 14.11% -34.27% 323.53%  
Operating expenses 98.968 M 105.761 M 112.357 M 175.519 M 184.284 M 162.690 M 129.597 M
Selling general and admin 31.408 M 31.833 M 37.757 M 77.186 M 54.650 M 41.628 M 33.658 M
Research and development 67.560 M 73.928 M 74.600 M 98.333 M 129.634 M 121.062 M 95.939 M
Total expenses 110.134 M 105.761 M 112.357 M 175.519 M 184.284 M 162.690 M 129.597 M
    -3.97% 6.24% 56.22% 4.99% -11.72% -20.34%  
Operating income -96.340 M -100.543 M -98.354 M -183.767 M -191.368 M -172.202 M -108.335 M
Ebit -96.340 M -98.063 M -95.675 M -178.898 M -202.645 M -162.250 M -108.103 M
Pretax income -92.152 M -98.063 M -95.675 M -178.898 M -202.645 M -162.250 M -108.103 M
    6.41% -2.44% 86.99% 13.27% -19.93% -33.37%  
Income tax -779.000 K -523.000 K 167.000 K 8.000 K -158.000 K 3.000 K 19.000 K
Net income basic -91.373 M 0.000 0.000 0.000 0.000 0.000 0.000
    100.00%            
Net income -91.373 M -97.540 M -95.842 M -178.906 M -202.487 M -162.253 M -108.122 M
    -6.75% 1.74% -86.67% -13.18% 19.87% 33.36%